Related Experiment Video
Updated: Jul 3, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Evidence for stepwise formation of amyloid fibrils by the mouse prion protein
Shweta Jain1, Jayant B Udgaonkar
1National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore 560065, India.
Abstract:
The full-length mouse prion protein, moPrP, is shown to form worm-like amyloid fibrils at pH 2 in the presence of 0.15 M NaCl, in a slow process that is accelerated at higher temperatures. Upon reduction in pH to 2, native moPrP transforms into a mixture of soluble beta-rich oligomers and alpha-rich monomers, which exist in a slow, concentration-dependent equilibrium with each other. It is shown that only the beta-rich oligomers and not the alpha-rich monomers, can form worm-like amyloid fibrils. The mechanism of formation of the worm-like amyloid fibrils from the beta-rich oligomers has been studied with four different physical probes over a range of temperatures and over a range of protein concentrations. The observed rate of fibrillation is the same, whether measured by changes in ellipticity at 216 nm, in thioflavin fluorescence upon binding, or in the mean hydrodynamic radius. The observed rate is significantly slower when monitored by total scattering intensity, suggesting that lateral association of the worm-like fibrils occurs after they form. The activation energy for worm-like fibril formation was determined to be 129 kJ/mol. The observed rate of fibrillation increases with an increase in protein concentration, but saturates at protein concentrations above 50 microM. The dependence of the observed rate of fibrillation on protein concentration suggests that aggregate growth is rate-limiting at low protein concentration and that conformational change, which is independent of protein concentration, becomes rate-limiting at higher protein concentrations. Hence, fibril formation by moPrP occurs in at least two separate steps. Longer but fewer worm-like fibrils are seen to form at low protein concentration, and shorter but more worm-like fibrils are seen to form at higher protein concentrations. This observation suggests that the beta-rich oligomers grow progressively in size to form critical higher order-oligomers from which the worm-like amyloid fibrils then form.
Insights
Mouse prion protein (moPrP) forms amyloid fibrils via beta-rich oligomers at low pH. Fibril formation involves multiple steps, with aggregate growth and conformational changes influencing the rate and structure.
Area of Science:
- Biochemistry
- Structural Biology
- Biophysics
Background:
- Prion diseases are linked to misfolding and aggregation of prion proteins.
- Understanding the structural transitions of prion proteins is crucial for disease research.
Purpose of the Study:
- To investigate the mechanism of amyloid fibril formation by mouse prion protein (moPrP).
- To characterize the conditions and kinetics of worm-like amyloid fibril formation from moPrP.
Main Methods:
- Utilized biophysical techniques including circular dichroism, thioflavin fluorescence, dynamic light scattering, and total scattering intensity.
- Studied the effect of pH, salt concentration, temperature, and protein concentration on fibril formation.
- Determined the activation energy for fibril formation.
Main Results:
- Mouse prion protein (moPrP) forms worm-like amyloid fibrils at pH 2 and 0.15 M NaCl.
- Fibril formation proceeds from soluble beta-rich oligomers, not alpha-rich monomers.
- Fibrillation rate is dependent on protein concentration, suggesting a multi-step process involving aggregate growth and conformational changes.
- Activation energy for fibril formation was determined to be 129 kJ/mol.
- Fibril morphology (length and number) varies with protein concentration.
Conclusions:
- Mouse prion protein aggregation into amyloid fibrils is a complex, multi-step process.
- Beta-rich oligomers are the direct precursors to worm-like amyloid fibrils.
- Protein concentration influences the kinetics and structural outcome of moPrP fibrillation.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology

